MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617080153 A) filed by Genome Therapeutics Ltd on June 29, 2026, for Novel Compounds.
Inventor includes Meo, Paul.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts, solvates and prodrugs thereof, wherein R1, R2, R3, R4, X1, X2, X3, X4, Q1, A1, A2, A3, A4, A5 and A6 are as defined in the specification, and antibody-drug conjugates (ADCs) comprising the compounds. The present invention also relates to processes for the preparation of the compounds and ADCs, pharmaceutical compositions containing them and their use in therapy, particularly for use in treating cancers.
Disclaimer: Curated by HT Syndication.
